DiaSorin S.p.A. (DSRLF)
USD 109.01
(0.0%)
USD 109.01
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1 Billion USD | -15.25% |
| 2022 | 1.18 Billion USD | 5.36% |
| 2021 | 1.12 Billion USD | 401.97% |
| 2020 | -373.45 Million USD | -159.36% |
| 2019 | -143.98 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 808.24 Million EUR | -17.09% |
| 2024 Q2 | 859.54 Million EUR | 14.76% |
| 2023 Q4 | 903.43 Million EUR | 2.71% |
| 2023 FY | 1 Billion USD | -15.25% |
| 2023 Q2 | 1.02 Billion USD | 11.56% |
| 2023 Q3 | 879.58 Million EUR | -14.35% |
| 2023 Q1 | 920.59 Million EUR | -22.52% |
| 2022 Q3 | 991.96 Million EUR | -5.42% |
| 2022 FY | 1.18 Billion USD | 5.36% |
| 2022 Q1 | 951.65 Million EUR | -4.08% |
| 2022 Q2 | 1.04 Billion EUR | 10.21% |
| 2022 Q4 | 1.18 Billion USD | 19.78% |
| 2021 Q2 | -368.55 Million EUR | 20.13% |
| 2021 FY | 1.12 Billion USD | 401.97% |
| 2021 Q3 | 1.21 Billion EUR | 429.16% |
| 2021 Q4 | 992.13 Million EUR | -18.22% |
| 2021 Q1 | -461.43 Million EUR | -51.18% |
| 2020 Q1 | -199.58 Million EUR | -55.59% |
| 2020 Q3 | -300.3 Million EUR | -168.73% |
| 2020 Q4 | -305.22 Million EUR | -1.64% |
| 2020 FY | -373.45 Million USD | -159.36% |
| 2020 Q2 | -111.74 Million EUR | 44.01% |
| 2019 FY | -143.98 Million USD | 0.0% |
| 2019 Q4 | -128.27 Million EUR | 11.39% |
| 2019 Q3 | -144.75 Million EUR | -604.46% |
| 2019 Q2 | -20.54 Million EUR | 73.87% |
| 2019 Q1 | -78.63 Million EUR | -32.28% |
| 2018 Q4 | -59.44 Million EUR | 60.24% |
| 2018 Q3 | -149.52 Million EUR | -41.18% |
| 2018 Q2 | -105.91 Million EUR | 49.0% |
| 2018 Q1 | -207.68 Million EUR | -27.92% |
| 2017 Q4 | -162.36 Million EUR | -21.25% |
| 2017 Q2 | -77.82 Million EUR | 36.06% |
| 2017 Q1 | -121.73 Million EUR | -62.53% |
| 2017 Q3 | -133.9 Million EUR | -72.05% |
| 2016 Q2 | -6.57 Million EUR | 98.01% |
| 2016 Q1 | -330.08 Million EUR | -44.91% |
| 2016 Q3 | -52.3 Million EUR | -695.18% |
| 2016 Q4 | -74.89 Million EUR | -43.19% |
| 2015 Q1 | -206.21 Million EUR | -20.5% |
| 2015 Q4 | -227.78 Million EUR | -17.11% |
| 2015 Q3 | -194.5 Million EUR | -25.88% |
| 2015 Q2 | -154.51 Million EUR | 25.07% |
| 2014 Q1 | -142.29 Million EUR | -5.51% |
| 2014 Q2 | -116.63 Million EUR | 18.03% |
| 2014 Q3 | -152.28 Million EUR | -30.56% |
| 2014 Q4 | -171.12 Million EUR | -12.38% |
| 2013 Q2 | -76.53 Million EUR | 17.73% |
| 2013 Q3 | -113.71 Million EUR | -48.59% |
| 2013 Q1 | -93.03 Million EUR | 0.0% |
| 2013 Q4 | -134.86 Million EUR | -18.6% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | -45547.604% |
| Arrayit Corporation | 1.05 Million USD | -95296.479% |
| Atlantic International Corp. | 236.49 Thousand USD | -425694.158% |
| Biocept, Inc. | -788 Thousand USD | 127890.121% |
| Bioqual, Inc. | -12 Million USD | 8486.586% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | -4428353.982% |
| DermTech, Inc. | 17.65 Million USD | -5604.334% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 275.895% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 13750.516% |
| iMD Companies, Inc. | 1.11 Million USD | -90138.688% |
| IDenta Corp. | 524.85 Thousand USD | -191760.972% |
| Interpace Biosciences, Inc. | 7.69 Million USD | -12987.941% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | 3736320.507% |
| InVitro International | -313.14 Thousand USD | 321674.925% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | -64206.606% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | 141232379.243% |
| Medical Imaging Corp. | 3.79 Million USD | -26463.002% |
| NovelStem International Corp. | 3.52 Million USD | -28495.083% |
| Optigenex Inc. | 8.93 Million USD | -11171.42% |
| PharmChem, Inc. | -1.49 Million USD | 67483.391% |
| Proteome Sciences plc | 14.57 Million USD | -6809.8% |
| Response Genetics, Inc | -13.08 Million USD | 7795.141% |
| Rennova Health, Inc. | 14.82 Million USD | -6690.253% |
| RushNet, Inc. | 4.8 Million USD | -20875.186% |
| ScreenPro Security Inc. | 135.58 Thousand USD | -742575.402% |
| Stella Diagnostics Inc. | 6.19 Million USD | -16159.915% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | -56332.791% |
| Todos Medical Ltd. | 38.31 Million USD | -2528.246% |